Enhanced protection against pulmonary hypertension with sildenafil and endothelial progenitor cell in rats
Enhanced protection against pulmonary hypertension with sildenafil and endothelial progenitor cell in rats
复制标题
DOI:
10.1016/j.ijcard.2011.05.002
复制
发表时间:
2012-12-15
影响因子:
3.5
通讯作者:
Yip, Hon-Kan
中科院分区:
文献类型:
--
作者:
Sun, Cheuk-Kwan;Lin, Yu-Chun;Yip, Hon-Kan
Background: Sildenafil and bone marrow-derived endothelial progenitor cells (BMDEPCs) have been shown to ameliorate monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) in the rat. We test whether combined sildenafil and BMDEPC treatment exerts additional protection against MCT-induced PAH in rats.Methods: Male Sprague-Dawley rats were randomized to receive saline injection only (group 1), MCT (70 mg/kg) only (group 2), MCT plus autologous BMDEPC (2.0x10(6) cells) transplantation (group 3), MCT with sildenafil (30 mg/kg/day) (group 4), and MCT with combined BMDEPCs-sildenafil (30 mg/kg/day) (group 5). Intravenous BMDEPC and oral sildenafil were given on day 3 after MCT administration. Hemodynamics were analyzed using Labchart software, whereas cellular and molecular parameters were measured using flow cytometry, real-time PCR, TUNEL assay, Western blot, and immunohistochemical staining.Results: By day 35 following MCT treatment, lower expression of connexin43, protein kinase C-epsilon, Bcl-2, and endothelial nitric oxide synthase and higher expression of tumor necrosis factor-alpha and caspase 3 were found in right ventricle (RV) and lung in group 2 compared with other groups (all p